samedan logo
 
 
spacer
home > pmps > spring 2002 > packaging for a safer future in the use of medicines
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging for a Safer Future in the Use of Medicines

In recent years, Government legislation has forced the enactment of EU directive 92/27, relating to rules and regulations surrounding the design of medicines packaging in the pharmaceutical industry. The UK had been lagging behind the rest of Europe in this area for some time. The primary aim of the legislation was to ensure that patients take their medication in the right way and at the right time. Each dispensed pack should also carry the batch number and date of product expiry, thus ensuring that patients are always dispensed a viable product that can be easily traced back to its source of manufacture should a problem occur.

The legislation means that bulk packs of up to 1,000 tablets are no longer the main pack format for dispensing medicines into the community. The majority of packs should now only contain a maximum of four weeks' supply of medicine.

Pharmaceutical companies duly repacked their product ranges according to the guideline. In doing so, two main reactions were triggered. Firstly, perhaps for the first time, pharmacists became aware that when dispensing product from bulk packs, they had been heavily reliant on a number of prompts such as colour, feel, smell or size to aid them in the correct identification of product during the dispensing process. The new patient packs removed many or all of these prompts.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Helen Toogood, Marketing Manager UK of Alpharma Limited Helen Toogood joined Alpharma's marketing department in 1992 and has held a number of key positions, including Product Manager and Portfolio Manager, prior to being promoted in 2000 to Marketing Manager UK.
She currently leads a team with a remit for the UK that covers branding, key customer support, communications, product and portfolio management.
She played a key role in Alpharma's Pan-European, cross-functional new pack design team and continues to work alongside the company's regulatory team. This involves responsibility for ensuring that all products comply with the latest Government legislation with the company's objective to provide cost-effective medicines of the highest quality to the widest audience possible..

spacer
Helen Toogood
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

BASi Opens New Office in Europe

12th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement